Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwideENDRIKAT, Jan; GERLINGER, Christoph; RICHARD, Stephanie et al.Contraception (Stoneham). 2011, Vol 84, Num 6, pp 549-557, issn 0010-7824, 9 p.Article

Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrelFOEGH, Marie; ARCHER, David F; STANCZYK, Frank Z et al.Contraception (Stoneham). 2013, Vol 87, Num 2, pp 201-211, issn 0010-7824, 11 p.Article

Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimensBRACHE, Vivian; COCHON, Leila; DENIAUD, Maëva et al.Contraception (Stoneham). 2013, Vol 88, Num 5, pp 611-618, issn 0010-7824, 8 p.Article

Ovulation inhibition by estetrol in an in vivo modelCOELINGH BENNINK, Herjan J. T; SKOUBY, Sven; BOUCHARD, Philippe et al.Contraception (Stoneham). 2008, Vol 77, Num 3, pp 186-190, issn 0010-7824, 5 p.Article

Maintenance of ovulation inhibition with the 75-μg desogestrel-only contraceptive pill (cerazette®) after scheduled 12-h delays in tablet intakeKORVER, Tjeerd; KLIPPING, Christine; HEGER-MAHN, Doris et al.Contraception (Stoneham). 2005, Vol 71, Num 1, pp 8-13, issn 0010-7824, 6 p.Article

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive : results of two prospective, randomized, open-label studiesENDRIKAT, Jan; PARKE, Susanne; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 3, pp 218-225, issn 0010-7824, 8 p.Article

Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal womenBRACHE, Vivian; SITRUK-WARE, Regine; SUSSMAN, Heather et al.Contraception (Stoneham). 2012, Vol 85, Num 5, pp 480-488, issn 0010-7824, 9 p.Article

Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian womenANZAI, Yuzuru; HEGER-MAHN, Doris; SCHELLSCHMIDT, Ilka et al.Contraception (Stoneham). 2012, Vol 86, Num 1, pp 28-34, issn 0010-7824, 7 p.Article

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenKLIPPING, Christine; DUIJKERS, Ingrid; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 1, pp 16-25, issn 0010-7824, 10 p.Article

Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimenARCHER, David F; KOVALEVSKY, George; BALLAGH, Susan A et al.Contraception (Stoneham). 2009, Vol 80, Num 3, pp 245-253, issn 0010-7824, 9 p.Article

Ovarian function with the contraceptive vaginal ring or an oral contraceptive:a randomized studyDUIJKERS, Ingrid J. M; KLIPPING, Christine; VERHOEVEN, Carole H. J et al.Human reproduction (Oxford. Print). 2004, Vol 19, Num 11, pp 2668-2673, issn 0268-1161, 6 p.Article